Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A healthcare professional can assess your individual clinical circumstances, review your current medications for potential interactions, and advise on whether you may be eligible for existing licensed treatments or clinical trial participation
Scott Sigman MD The reason why there will NEVER be any large human clinical trials on BPC-157 (and all other peptides) is because it takes millions/billions of dollars to secure a patent
Recent Blogs Disclaimer : Zeelab Pharmacy provides health information for knowledge only
Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Specifications Molecular Formula: C 62 H 98 N 16 O 22 Molecular Weight: 1419.556 g/mol Sequence: L-Valine,glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-Lprolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-;glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyllysyl-L-prolyl-L-alanyl-L- alpha-aspartylL-alpha-aspartyl-L-alanylglycyl-L-leucyl-L-valine BPC-157 Peptide Research BPC-157 and Wound Healing The GI tract's mucosal barrier is considered to protect the underlying tissues from the harmful actions of bile, gastric acid, and other compounds necessary for the digestion and absorption of nutrients from food
